Related Experiment Video
Updated: Aug 23, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta
Craig F Munns1, Frank Rauch, Richard J Mier
1Genetics Unit, Shriners Hospital for Children and McGill University, Montréal, Québec, Canada.
Insights
The first pamidronate infusion cycle may cause temporary breathing problems in infants with severe osteogenesis imperfecta (OI) and existing respiratory issues. Close monitoring during this initial treatment is crucial for managing potential adverse respiratory events.
Area of Science:
- Pediatrics
- Pharmacology
- Genetics
Background:
- Severe osteogenesis imperfecta (OI) is a rare genetic disorder characterized by brittle bones.
- Pamidronate is a bisphosphonate used to treat OI by reducing bone resorption.
- Infants with severe OI often have associated medical conditions, including respiratory compromise.
Observation:
- An observational trial involved 59 infants with severe OI receiving cyclical intravenous pamidronate.
- Routine observations were conducted during each infusion cycle.
- Four infants (7%) with pre-existing respiratory compromise experienced respiratory distress during their first pamidronate cycle.
Findings:
- Adverse respiratory events, including respiratory distress, were observed in a subset of infants during the initial pamidronate cycle.
- The respiratory distress was manageable with bronchodilator therapy, with two infants requiring intensive care.
- No recurrence of respiratory distress was noted in subsequent pamidronate infusion cycles.
Implications:
- The first pamidronate infusion cycle may precipitate acute respiratory deterioration in vulnerable infants with severe OI.
- Potential etiologies include cytokine release or hemodynamic changes from fluid administration.
- Close monitoring during the first treatment cycle is essential for early detection and management of respiratory complications.
Abstract:
This report aims to describe the adverse respiratory events associated with the first pamidronate cycle in four infants with severe osteogenesis imperfecta (OI) who were less than 2 years of age. Fifty-nine infants with severe OI were commenced on cyclical intravenous pamidronate therapy in an observation trial. Routine observations were measured during each infusion cycle. During the first treatment cycle, four infants (7%) with preexisting respiratory compromise developed respiratory distress. The respiratory distress was successfully managed with bronchodilator therapy. Two of the infants required intensive care admission. There was no recurrence of respiratory distress with subsequent pamidronate infusion cycles. In infants with severe OI and preexisting respiratory compromise, the first pamidronate infusion cycle may be associated with an acute deterioration of respiratory function. The etiology is unclear but may involve cytokine release and/or hemodynamic compromise from fluid administration during the first infusion cycle. Close monitoring throughout the first treatment cycle is of paramount importance.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Acute Respiratory Failure-IV
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Breathing